Directory → Organotropona funds → Cardiovascular funds → Antiarrhythmic funds → Pamaton
This page is translated automatically with a help of Google Translate
PamatonSee also PhenytoinRoman namePamatonThe composition and the form of1 tablet coated liner contains magnesium bis Dl-aspartata 175 mg (equivalent to 11.8 mg magnesium) and potassium Dl-aspartata 166 mg (equivalent to 36.2 mg of potassium); in a contour acheikova packing 10 pcs. , in a cardboard bundle five packages.FarmakodinamikaIndicationsAdults, cardiac insufficiency in the face of gipokaliemii, stenocardia, gipokaliemia (uncontrollable vomiting, diarrhoea, prolonged treatment naperstanki glycosides, and korticosteroidami dioreticakimi means).Pregnancy and lactationContraindicated in the first trimester of pregnancy. At the time of treatment should stop breastfeeding.ContraindicationsHypersensitivity, renal failure, oliguria, anuria, giperkaliemia violation of amino acids, the blockade heart gipotenzia, heavy infants, the disease Addison, gemoliz.Side-EffectsAetiology, human peripheral blood circulation.Patient interactionRisk giperkaliemii increase NPVS, kalisberegate dioretiki, ciclosporin, beta-adrenoblokatora, heparin, ACE inhibitors, gipermagniemii drugs-calcium neiromyshecna blockade, atrakuroni, dekametoni, suktinhlorid, suxamethonium. Magnesium reduces the effectiveness neomitina, polimiksina B, tetracycline and streptomycin, strengthens central anesthetics activity and toxicity of cardiac glycosides.PrecautionsBe wary appoint patients with dehydration (diarrhoea, vomiting).Dosing and AdministrationInside, after eating, 2-3 table. (for the prevention or maintenance therapy on one table.) 3 times a day.Storage conditionsIn dry, the dark place at a temperature of 15-21 ° CShelf life3 yearsThe registration013988/01-2002 (Ann.2004) |
All products of this group |

